Kunli Du

442 total citations
25 papers, 269 citations indexed

About

Kunli Du is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Kunli Du has authored 25 papers receiving a total of 269 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Kunli Du's work include Cancer, Hypoxia, and Metabolism (6 papers), Colorectal Cancer Surgical Treatments (4 papers) and Gastric Cancer Management and Outcomes (4 papers). Kunli Du is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), Colorectal Cancer Surgical Treatments (4 papers) and Gastric Cancer Management and Outcomes (4 papers). Kunli Du collaborates with scholars based in China, Saint Kitts and Nevis and Japan. Kunli Du's co-authors include Jianyong Zheng, Shouru Zhang, Xingye Wu, Zhongxue Fu, Jinlai Wei, Jinbao Guo, Gaozan Zheng, Zhenyu Xie, Liaoran Niu and Ruikai Li and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Cellular and Molecular Life Sciences.

In The Last Decade

Kunli Du

23 papers receiving 265 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kunli Du China 11 122 121 72 66 46 25 269
Jun You China 10 149 1.2× 92 0.8× 69 1.0× 57 0.9× 95 2.1× 35 296
Zhongxue Su China 10 183 1.5× 124 1.0× 132 1.8× 66 1.0× 34 0.7× 11 321
Wei Wen China 11 179 1.5× 90 0.7× 127 1.8× 60 0.9× 48 1.0× 25 350
Rongjie Zhao China 9 162 1.3× 60 0.5× 102 1.4× 42 0.6× 56 1.2× 21 279
Liaoran Niu China 11 157 1.3× 100 0.8× 98 1.4× 36 0.5× 71 1.5× 30 325
Huiyu Lu China 11 120 1.0× 144 1.2× 76 1.1× 25 0.4× 82 1.8× 29 303
Xiangbin Wan China 10 134 1.1× 122 1.0× 100 1.4× 84 1.3× 81 1.8× 24 327
Meifang Xu China 11 97 0.8× 129 1.1× 77 1.1× 55 0.8× 43 0.9× 30 286
Annalisa Comandatore Italy 8 122 1.0× 95 0.8× 97 1.3× 51 0.8× 44 1.0× 30 246
Huajie Zong China 6 219 1.8× 114 0.9× 160 2.2× 42 0.6× 41 0.9× 10 317

Countries citing papers authored by Kunli Du

Since Specialization
Citations

This map shows the geographic impact of Kunli Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kunli Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kunli Du more than expected).

Fields of papers citing papers by Kunli Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kunli Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kunli Du. The network helps show where Kunli Du may publish in the future.

Co-authorship network of co-authors of Kunli Du

This figure shows the co-authorship network connecting the top 25 collaborators of Kunli Du. A scholar is included among the top collaborators of Kunli Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kunli Du. Kunli Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Zhenyu, Gaozan Zheng, Liaoran Niu, et al.. (2024). SPP1 macrophages in colorectal cancer: Markers of malignancy and promising therapeutic targets. Genes & Diseases. 12(3). 101340–101340. 9 indexed citations
2.
Du, Kunli, Pengfei Wang, Gaozan Zheng, et al.. (2024). Activation of RhoA/ROCK2 signaling by hypoxia-inducible factor 1α in promoting tumor growth and metastasis in human colon cancer. Journal of Gastrointestinal Oncology. 15(1). 237–249. 6 indexed citations
3.
Xie, Zhenyu, Liaoran Niu, Kunli Du, et al.. (2024). Endothelial cell heterogeneity in colorectal cancer: tip cells drive angiogenesis. Cellular and Molecular Life Sciences. 81(1). 365–365. 4 indexed citations
4.
Du, Kunli, Wei Zhou, Gaozan Zheng, et al.. (2024). Effect of perioperative blood transfusion on complications and prognosis after radical gastrectomy in elderly patients: a retrospective study of 1,666 cases. Journal of Gastrointestinal Oncology. 15(2). 555–565. 1 indexed citations
5.
Zheng, Gaozan, Kunli Du, Lili Duan, et al.. (2024). Prognostic value of dynamic changes of pre- and post-operative tumor markers in colorectal cancer. Clinical & Translational Oncology. 26(8). 2047–2059. 3 indexed citations
6.
Wang, Xiang-Xu, Lihong Wu, Qingqing Liu, et al.. (2023). Cuproptosis-Mediated Patterns Characterized by Distinct Tumor Microenvironment and Predicted the Immunotherapy Response for Gastric Cancer. ACS Omega. 8(12). 10851–10862. 10 indexed citations
7.
Ren, Guangming, Ruikai Li, Gaozan Zheng, et al.. (2023). Prognostic value of normal levels of preoperative tumor markers in colorectal cancer. Scientific Reports. 13(1). 22830–22830. 12 indexed citations
8.
Xie, Zhenyu, Liaoran Niu, Gaozan Zheng, et al.. (2023). Single-cell analysis unveils activation of mast cells in colorectal cancer microenvironment. Cell & Bioscience. 13(1). 217–217. 20 indexed citations
9.
Niu, Liaoran, Qi Wang, Fan Feng, et al.. (2023). Small extracellular vesicles-mediated cellular interactions between tumor cells and tumor-associated macrophages: Implication for immunotherapy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(2). 166917–166917. 10 indexed citations
10.
Du, Kunli, Gaozan Zheng, Shisen Li, et al.. (2022). Variation of the ileocolic artery and superior mesenteric artery in a patient with right-sided colon cancer with Lynch syndrome: a case report. Annals of Translational Medicine. 10(17). 939–939.
11.
12.
Chai, Xiaoyan, Xiao Wu, Kunli Du, et al.. (2022). Expression of HIF-1α, ANXA3, CD133 and their associations with clinicopathological parameters in human colon carcinoma. Translational Cancer Research. 11(6). 1644–1651. 3 indexed citations
13.
Du, Kunli, Xinyou Wang, Shisen Li, et al.. (2021). Construction of a gut microbiota-gene-pathway network to reveal the molecular mechanisms underlying right- and left-sided colorectal cancer. FEMS Microbiology Letters. 368(21-24). 2 indexed citations
14.
Yang, Jianjun, Guanghui Xu, Jiyang Zheng, et al.. (2020). PD-L1 expression on tumor cells and tumor infiltrating immune cells in Chinese colorectal cancer patients.. Journal of Clinical Oncology. 38(15_suppl). e16111–e16111. 1 indexed citations
15.
Du, Kunli, et al.. (2020). ANXA3 is upregulated by hypoxia-inducible factor 1-alpha and promotes colon cancer growth. Translational Cancer Research. 9(12). 7440–7449. 12 indexed citations
16.
Zhang, Ying, Jianyong Zheng, Xiaomin Wang, et al.. (2019). Prognostic value of ABO blood group in a Chinese population in Northwest China region with curatively resected rectal cancer. Journal of Cancer. 10(26). 6584–6593. 4 indexed citations
17.
Du, Kunli, et al.. (2018). High Expression of PhospholipaseD2 Induced by Hypoxia Promotes Proliferation of Colon Cancer Cells through Activating NF- κ Bp65 Signaling Pathway. Pathology & Oncology Research. 26(1). 281–290. 8 indexed citations
18.
19.
Zhang, Shouru, et al.. (2014). Peroxiredoxin 2 is involved in vasculogenic mimicry formation by targeting VEGFR2 activation in colorectal cancer. Medical Oncology. 32(1). 414–414. 32 indexed citations
20.
Du, Kunli, et al.. (2014). Hypoxia-inducible factor 1-alpha up-regulates the expression of phospholipase D2 in colon cancer cells under hypoxic conditions. Medical Oncology. 32(1). 394–394. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jun You Breakdown of academic impact, for papers by Zhongxue Su Breakdown of academic impact, for papers by Wei Wen Breakdown of academic impact, for papers by Rongjie Zhao Breakdown of academic impact, for papers by Liaoran Niu Breakdown of academic impact, for papers by Huiyu Lu Breakdown of academic impact, for papers by Xiangbin Wan Breakdown of academic impact, for papers by Meifang Xu Breakdown of academic impact, for papers by Annalisa Comandatore Breakdown of academic impact, for papers by Huajie Zong
Rankless by CCL
2026